Photodynamic therapy – significance in oncology

Authors

  • Beata Mossakowska Zakład Onkologii Molekularnej i Translacyjnej Narodowy, Instytut Onkologii im. Marii Skłodowskiej-Curie – Państwowy Instytut Badawczy, Roentgena 5, 02–781 Warszawa
  • Anna Fabisiewicz Department of Molecular and Translational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Roentgena 5, 02–781 Warsaw https://orcid.org/0000-0002-9334-1773
  • Janusz Siedlecki Department of Molecular and Translational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Roentgena 5, 02–781 Warsaw https://orcid.org/0000-0003-4889-5416

DOI:

https://doi.org/10.18388/pb.2021_394

Abstract

Photodynamic therapy (PDT) is one of the least toxic methods causing the death of  cancer cells. Photosensitizer (PS) applied to a patient accumulates in the tumor, where under the appropriate wavelength and insensitivity of light is activated. Activated PS in the presence of oxygen produces reactive oxygen species (ROS), which make significant damage leading to the destruction of cancer cells by apoptosis, necrosis or autophagic process. Moreover, PDT causes an acute local inflammatory response that is involved in removing dead cells, restoring normal tissue homeostasis, and sometimes leads to the development of systemic immunity. However, some cells may survive treatment and develop resistance. Mechanisms, which lead to decrease of the level of PS in cells may be involved in the cytoprotection of cancer cells from PDT. Furthermore, increased activity of antioxidant mechanisms, overexpression of molecular chaperones and activation of survival pathways can protect cells from PDT.

Downloads

Download data is not yet available.
Streszczenie graficzne

Published

2021-07-19

Issue

Section

Articles